Definition and epidemiology
Menopause is defined retrospectively as the point 12 months after a woman's final menstrual period, marking the permanent end of ovarian follicular activity and reproductive capacity. The perimenopause (menopausal transition) refers to the years preceding this, characterized by irregular cycles and fluctuating hormone levels, while postmenopause refers to all time after.
- Average age of natural menopause: approximately 51 years (range roughly 45-55)
- Premature ovarian insufficiency: menopause before age 40
- Early menopause: between ages 40-45
- Surgical menopause follows bilateral oophorectomy and causes an abrupt, often more severe symptom onset
- Smoking is associated with menopause occurring 1-2 years earlier
Menopause is a universal, physiologic event in women who live long enough; it is not a disease, but the associated symptoms and long-term estrogen deficiency effects are clinically significant.
- Menopause = 12 consecutive months of amenorrhea; it is a clinical diagnosis
- FSH rises before LH due to loss of inhibin feedback from declining follicles
- Average age of natural menopause is about 51 years; before 40 = premature ovarian insufficiency
- Hot flashes result from hypothalamic thermoregulatory instability from estrogen withdrawal
- Women with a uterus need estrogen + progestogen; progestogen prevents endometrial hyperplasia
- Vaginal estrogen is first-line for isolated genitourinary symptoms with minimal systemic risk
- HT is most favorable when started before age 60 or within 10 years of menopause
- Fezolinetant and SSRIs/SNRIs are non-hormonal options for vasomotor symptoms
Etiology and risk factors
The underlying cause is depletion of the finite ovarian follicle pool present since fetal life. As follicles are progressively lost through ovulation and atresia, the ovaries become increasingly unresponsive to pituitary gonadotropins.
Factors associated with earlier menopause
- Smoking
- Nulliparity
- Family history of early menopause
- Chemotherapy or pelvic radiation
- Autoimmune conditions (e.g., autoimmune oophoritis, thyroiditis)
- Chromosomal conditions (e.g., Turner syndrome, fragile X premutation) — associated with premature ovarian insufficiency
- Bilateral oophorectomy (surgical menopause, immediate)
Factors associated with later menopause
- Higher parity
- Obesity (peripheral aromatization increases estrogen exposure)
- Later menarche in some studies
Pathophysiology
The core process is depletion of ovarian follicles, leading to decreased production of estradiol and inhibin by the granulosa cells.
- Falling inhibin and estradiol remove negative feedback on the hypothalamic-pituitary axis
- FSH rises first and most markedly (loss of inhibin feedback), followed by LH elevation
- Estrogen deficiency affects estrogen-receptor-rich tissues throughout the body: hypothalamus (vasomotor instability), vaginal and urethral mucosa (atrophy), bone (accelerated resorption), and cardiovascular endothelium
- Vasomotor symptoms (hot flashes) are thought to result from a narrowed thermoregulatory set-point in the hypothalamus triggered by estrogen withdrawal
- Bone loss accelerates sharply in the first few years after the final menstrual period due to unopposed osteoclast activity
Clinical features
Symptoms vary widely in severity and are driven by estrogen withdrawal.
Vasomotor
- Hot flashes (flushing, sweating, palpitations), often worse at night
- Night sweats and sleep disruption
Genitourinary syndrome of menopause
- Vaginal dryness, dyspareunia
- Urinary urgency, frequency, recurrent UTIs
- Vaginal atrophy on exam
Psychological / cognitive
- Mood lability, irritability, low mood
- Difficulty concentrating, "brain fog"
- Sleep disturbance
Other
- Irregular, then absent, menses
- Decreased libido
- Skin and hair changes
- Joint aches
Most vasomotor symptoms peak in the first 1-2 years after the final menstrual period and gradually resolve over several years, though genitourinary symptoms tend to persist or worsen without treatment.
Diagnosis
Menopause is primarily a clinical diagnosis in women of the typical age range.
- 12 consecutive months of amenorrhea without another identifiable cause, in a woman of appropriate age
- Hormone testing is not required in women over 45 with typical symptoms and cycle changes
- Hormone testing is useful when the picture is ambiguous (e.g., age under 40-45, prior hysterectomy, use of hormonal contraception masking cycle changes)
Hormone pattern
| Test | Finding in menopause |
|---|---|
| FSH | Elevated (often >25-30 IU/L) |
| LH | Elevated |
| Estradiol | Low |
| AMH | Very low/undetectable |
FSH should ideally be measured on more than one occasion, as perimenopausal levels fluctuate. In women under 40 with amenorrhea and elevated FSH on two occasions at least 4 weeks apart, consider premature ovarian insufficiency and evaluate for underlying causes (karyotype, autoimmune screen, fragile X testing).
Differential diagnosis
- Pregnancy — always exclude in a woman with amenorrhea and reproductive potential
- Thyroid dysfunction — can cause irregular cycles, palpitations, mood change
- Premature ovarian insufficiency — menopause-like picture before age 40
- Hyperprolactinemia — amenorrhea with normal/low FSH
- Polycystic ovary syndrome — irregular cycles but typically younger age, different hormone profile
- Hypothalamic amenorrhea (stress, weight loss, excessive exercise) — low FSH/LH rather than elevated
- Panic disorder or anxiety — can mimic vasomotor symptoms
- Carcinoid syndrome or pheochromocytoma — rare mimics of flushing episodes
Management
Management is individualized based on symptom severity, patient preference, and risk factors.
Lifestyle and non-hormonal measures
- Layered clothing, cooling strategies, regular exercise, weight management
- Avoidance of triggers (caffeine, alcohol, spicy food) for vasomotor symptoms
- Vaginal moisturizers and lubricants for genitourinary symptoms
- Cognitive behavioral therapy for mood and sleep symptoms
Hormone therapy (HT)
- Most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause
- Estrogen alone for women without a uterus
- Estrogen plus progestogen for women with an intact uterus (progestogen protects against endometrial hyperplasia/cancer)
- Low-dose vaginal estrogen for isolated genitourinary symptoms, with minimal systemic absorption and no need for added progestogen in most cases
- Guideline bodies (NAMS/The Menopause Society, ACOG, NICE) generally agree HT is appropriate for symptomatic women under 60 or within 10 years of menopause onset who lack contraindications, with risks and benefits individualized
Contraindications to systemic HT
- History of breast or endometrial cancer
- Unexplained vaginal bleeding
- Active venous thromboembolism or high VTE risk
- Active or prior estrogen-sensitive cancer
- Severe active liver disease
- Coronary artery disease or prior stroke (relative contraindication, individualized)
Non-hormonal pharmacologic options (for vasomotor symptoms when HT is contraindicated or not desired)
- SSRIs/SNRIs (e.g., paroxetine, venlafaxine)
- Gabapentin
- Clonidine
- Fezolinetant (neurokinin-3 receptor antagonist) — newer non-hormonal option specifically for vasomotor symptoms
Bone health
- Calcium and vitamin D intake, weight-bearing exercise
- Bone density screening per guidelines (typically starting age 65, or earlier with risk factors)
- Bisphosphonates or other osteoporosis agents if osteoporosis develops
Complications and prognosis
Menopause itself is not a disease, but prolonged estrogen deficiency increases long-term health risks.
- Osteoporosis — accelerated bone loss, especially in the first 5-10 postmenopausal years; increased fracture risk
- Cardiovascular disease — loss of estrogen's protective effect contributes to rising cardiovascular risk after menopause
- Genitourinary syndrome of menopause — tends to be chronic and progressive without treatment, unlike vasomotor symptoms
- Sexual dysfunction — dyspareunia, decreased libido
- Vasomotor symptoms resolve spontaneously in most women within several years, though a minority experience them for a decade or more
Overall prognosis is excellent with appropriate symptom management and attention to long-term bone and cardiovascular health.
FSH "Finally Soars High" — remember FSH rises first and highest as the ovaries stop responding.
Practice questions
1. A 50-year-old woman reports 11 months of amenorrhea along with hot flashes and night sweats. Urine pregnancy test is negative. Which hormonal pattern is most consistent with her presentation?
2. A 54-year-old woman with an intact uterus has moderate hot flashes significantly affecting her sleep and quality of life. She has no history of breast cancer, VTE, or liver disease, and her last period was 14 months ago. She wants the most effective treatment for her symptoms. What is the most appropriate therapy?
3. A 37-year-old woman presents with 6 months of amenorrhea, hot flashes, and difficulty conceiving. FSH is elevated on two occasions four weeks apart, with low estradiol. Which of the following is the most appropriate next step?
Frequently asked questions
What causes menopause?
Menopause is caused by the natural depletion of ovarian follicles with aging, leading to declining estrogen and inhibin production. This loss of negative feedback causes FSH and LH to rise while estrogen falls. It can also be induced earlier by surgery (bilateral oophorectomy), chemotherapy, pelvic radiation, or autoimmune ovarian damage.
What are the first symptoms of menopause?
The earliest symptoms are usually irregular menstrual cycles followed by hot flashes and night sweats. Sleep disturbance, mood changes, and vaginal dryness often follow. Symptoms typically begin during perimenopause, the transition phase before periods stop completely, and vary considerably in severity between women.
How is menopause diagnosed?
Menopause is diagnosed clinically after 12 consecutive months without a menstrual period in a woman of typical age, without another cause for amenorrhea. Hormone testing is not usually necessary but can help in ambiguous cases, showing elevated FSH and low estradiol. Pregnancy and thyroid disease should be excluded if the picture is unclear.
Is menopause curable?
Menopause is not a disease and does not require a cure; it is a normal, permanent biological transition marking the end of reproductive function. Treatment focuses on managing symptoms such as hot flashes and vaginal dryness, and on reducing long-term risks like osteoporosis, using hormone therapy or non-hormonal options as needed.
Perimenopause vs menopause — what is the difference?
Perimenopause is the transitional period of irregular cycles and fluctuating hormones leading up to menopause, often lasting several years and marked by the onset of symptoms like hot flashes. Menopause itself is the single point in time defined retrospectively as 12 months after the final menstrual period. Postmenopause refers to everything after that point.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: N95
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.